OVARIAN FAILURE

This adverse event was reported 535 times

These drugs are most commonly taken by patients reporting OVARIAN FAILURE:

# Drug Count
0 CYCLOPHOSPHAMIDE 143
1 CYCLOPHOSPHAMIDE FOR INJECTION 143
2 CYCLOPHOSPHAMIDE INJECTION, SOLUTION 143
3 ETOPOSIDE 118
4 IFOSFAMIDE 92
5 IFOSFAMIDE FOR INJECTION 92
6 DOXORUBICIN 82
7 BUSULFAN 63
8 DACTINOMYCIN 55
9 METHOTREXATE SODIUM 38
See all common drugs associated with OVARIAN FAILURE

OVARIAN FAILURE is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 QUINIDINE SULFATE TABLET 13 0.0909
1 PROCAINAMIDE HYDROCHLORIDE 17 0.0688
2 ALLOGENIC THYMOCYTE-DEPLETED THYMUS TISSUE-AGDC 1 0.0345
3 DACTINOMYCIN 55 0.0249
4 CHLORPROMAZINE HYDROCHLORIDE 11 0.0115
5 NIROGACESTAT 5 0.0054
6 PENTOSTATIN 5 0.0048
7 IFOSFAMIDE FOR INJECTION 92 0.0043
8 BUSULFAN 63 0.0040
9 HYDRALAZINE HYDROCHLORIDE 10 0.0037
See all drugs enriched for association with OVARIAN FAILURE

OVARIAN FAILURE is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Actinomycin [EPC] 55 0.0249
1 Gamma Secretase Inhibitor [EPC] 5 0.0054
2 CD22-directed Immunoconjugate [EPC] 5 0.0017
3 Topoisomerase Inhibitor [EPC] 117 0.0015
4 CD3-directed Antibody [EPC] 1 0.0014
5 Gonadotropin [EPC] 3 0.0014
6 Alkylating Drug [EPC] 246 0.0010
7 Allylamine Antifungal [EPC] 6 0.0008
8 Hematopoietic Stem Cell Mobilizer [EPC] 1 0.0007
9 CCR5 Co-receptor Antagonist [EPC] 1 0.0004
See all drug classes enriched for association with OVARIAN FAILURE